Literature DB >> 2980285

Elevated plasma concentration of neuropeptide Y and low level of circulating adrenaline in elderly asthmatics during rest and acute severe asthma.

C Dahlöf1, P Dahlof, J M Lundberg, U Strömbom.   

Abstract

Twenty-five elderly asthmatic patients attending the internal medicine emergency ward because of an acute exacerbation of asthma were sampled, prior to acute treatment, for determination of systemic venous plasma levels of noradrenaline (NA), adrenaline (A) and neuropeptide Y-like immunoreactivity (NPY-LI). Whereas NA and NPY-LI were about two-fold higher than control values, plasma A levels were not significantly increased. Twelve of the asthmatic patients were also tested at resting stable conditions and were essentially asymptomatic. All values were then similar to those of control subjects (n = 28) except for a significantly higher NPY-LI plasma level in asthmatics. In seven of these patients a near maximal physical exercise test caused significantly increased NA, A and NPY-LI plasma levels. It is concluded that the acute asthma attack is associated with elevated NA and NPY-LI plasma levels, but an impaired A response. Furthermore, that circulating NPY under these conditions has a nervous rather than adrenal origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2980285     DOI: 10.1016/0952-0600(88)90003-8

Source DB:  PubMed          Journal:  Pulm Pharmacol        ISSN: 0952-0600


  3 in total

1.  Early postnatal exposure of mice to side-steam tobacco smoke increases neuropeptide Y in lung.

Authors:  Z-X Wu; K B Benders; D D Hunter; R D Dey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

2.  Epithelium-generated neuropeptide Y induces smooth muscle contraction to promote airway hyperresponsiveness.

Authors:  Shanru Li; Cynthia Koziol-White; Joseph Jude; Meiqi Jiang; Hengjiang Zhao; Gaoyuan Cao; Edwin Yoo; William Jester; Michael P Morley; Su Zhou; Yi Wang; Min Min Lu; Reynold A Panettieri; Edward E Morrisey
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

Review 3.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.